Biotech Values

[floblu14]

MNTA European/U.S. Patent Applications Update for RMF - Plus MNTA Overview of their Patent Estate -

1.EVALUATION OF COPOLYMER DIETHYLAMIDE 2013-01-17

Abstract:
Methods of analyzing glatiramer acetate (GA) or a polymeric precursor thereof are provided. The methods can include determining a level of one or more diethylamide-modified amino acids in a sample comprising GA or a polymeric precursor thereof, and selecting at least a portion of the sample based on the assessment of the one or more diethylamide-modified amino acids in the sample.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130117&CC=WO&NR=2013009885A2&KC=A2

2.STRUCTURE ASSESSMENT OF HETEROGENEOUS POLYPEPTIDE MIXTURES 2013-01-17

Abstract:
The present disclosure provides methods for assessing (e.g., measuring, analyzing, detecting, determining, evaluating, and/or estimating) the secondary structure of Glatiramer Acetate (GA) and, in some instances polymeric precursors of GA. The methods entail assessing the fraction of a sample of GA that is in alpha-helical conformation and/or assessing the fraction of a sample of GA that is in random coil conformation.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=1&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130117&CC=WO&NR=2013009864A1&KC=A1

3.CELL CULTURE PROCESS 2013-01-17

Abstract:
Polypeptides having target levels of C-terminal variants are described.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=2&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130117&CC=WO&NR=2013009648A2&KC=A2

4.NON-ANTICOAGULANT POLYSACCHARIDE COMPOSITIONS
2012-12-28

Abstract:
NON-ANTICOAGULANT POLYSACCHARIDE COMPOSITIONS AbstractPolysaccharide preparations lacking substantial anticoagulant activity are provided herein. Methods of making and using such preparations are provided.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=3&ND=3&adjacent=true&locale=en_EP&FT=D&date=20121228&CC=SG&NR=185925A1&KC=A1

5.Methods related to cell surface glycosylation 2012-10-17

Abstract:
The present disclosure provides methods for assessing the glycosylation of a target glycoprotein produced by a cell through analysis of cell-surface glycans on the cell. The present disclosure therefore teaches that glycosylation of cell surface proteins can serve as a proxy for glycosylation of other proteins.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20121017&CC=EP&NR=2511705A1&KC=A1

6.ANTENNARY FUCOSYLATION IN GLYCOPROTEINS FROM CHO CELLS
2012-10-10

Abstract:
The present invention provides methods of evaluating CHO cells and producing recombinant glycoproteins.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=1&ND=3&adjacent=true&locale=en_EP&FT=D&date=20121010&CC=EP&NR=2507627A2&KC=A2

7.N-ACETYLHEXOSAMINE-CONTAINING N-GLYCANS IN GLYCOPROTEIN PRODUCTS 2012-09-20

Abstract:
The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N- acetylglucosamine glycan.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20120920&CC=WO&NR=2012125553A2&KC=A2

8.GLYCOSYL TRANSFERASE FROM CHINESE HAMSTER AND RELATED METHODS 2012-09-19

Abstract not available

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=1&ND=3&adjacent=true&locale=en_EP&FT=D&date=20120919&CC=EP&NR=2499245A2&KC=A2

9.EVALUATING HEPARIN PREPARATIONS 2012-08-30

Abstract:
Methods of evaluating heparin preparations, e.g., for suitability for use as a drug or for use in making a drug, by determining the absence, presence or amount of a structural signature, wherein, e.g., the structural signature is indicative of the methods used to make the heparin preparation.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=2&ND=3&adjacent=true&locale=en_EP&FT=D&date=20120830&CC=WO&NR=2012115952A1&KC=A1


PATENTS

We license or own a patent portfolio of over 70 patent families, each of which includes United States patent applications and/or issued patents as well as foreign counterparts to certain United States patents and patent applications. Our patent portfolio includes issued or pending claims covering:

*Methods and technologies for characterizing polysaccharides and other heterogeneous mixtures

*The composition of matter and use of certain heparinases, heparinase variants and other enzymes

*Methods and technologies for synthesis of polysaccharides

*The composition of matter and use of certain novel low molecular weight heparin products, including M402

*Methods to identify, analyze and characterize glycoproteins

*Methods of manufacture of certain polysaccharide, polypeptide and complex protein or biologic products

http://www.momentapharma.com/technology/patents.php